Triple

T4210364
Position Surface form Disambiguated ID Type / Status
Subject Clinical and Translational Science Awards Program E93885 entity
Predicate partOf P40 FINISHED
Object National Center for Advancing Translational Sciences programs E16877 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Center for Advancing Translational Sciences programs | Statement: [Clinical and Translational Science Awards Program, partOf, National Center for Advancing Translational Sciences programs]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: National Center for Advancing Translational Sciences programs
Context triple: [Clinical and Translational Science Awards Program, partOf, National Center for Advancing Translational Sciences programs]
  • A. Clinical and Translational Science Awards Program
    The Clinical and Translational Science Awards Program is a U.S. national consortium that supports academic medical institutions in accelerating the translation of scientific discoveries into improved patient care and public health.
  • B. National Center for Advancing Translational Sciences chosen
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • C. Office of Translational Sciences
    The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
  • D. NCI-Designated Cancer Centers Program
    The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
  • E. National Institutes of Health intramural research program
    The National Institutes of Health intramural research program is a large, government-funded biomedical research enterprise in which NIH scientists conduct basic, translational, and clinical studies within NIH facilities.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451743608190808f41d17ccf2650 completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34810de648190b09c5e705cf0a74e completed March 12, 2026, 11:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69b5962ec4f8819085bef81ce71aa132 completed March 14, 2026, 5:09 p.m.
Created at: March 12, 2026, 11:03 p.m.